I
Iwan Ariawan
Researcher at University of Indonesia
Publications - 56
Citations - 1033
Iwan Ariawan is an academic researcher from University of Indonesia. The author has contributed to research in topics: Medicine & Logistic regression. The author has an hindex of 10, co-authored 45 publications receiving 803 citations. Previous affiliations of Iwan Ariawan include Integra Telecom.
Papers
More filters
Journal ArticleDOI
Neonatal resuscitation in low-resource settings: What, who, and how to overcome challenges to scale up?
Stephen Wall,Anne C C Lee,Anne C C Lee,Susan Niermeyer,Mike English,William J. Keenan,Wally Carlo,Zulfiqar A Bhutta,Abhay Bang,Indira Narayanan,Iwan Ariawan,Joy E Lawn +11 more
TL;DR: Each year approximately 10 million babies do not breathe immediately at birth, of which about 6 million require basic neonatal resuscitation, and the major burden is in low‐income settings, where health system capacity to provide neonatic resuscitation is inadequate.
Journal ArticleDOI
Determinants of the Stunting of Children Under Two Years Old in Indonesia: A Multilevel Analysis of the 2013 Indonesia Basic Health Survey
TL;DR: The odds of stunting increased significantly among children living in households with three or more children under five-years-old, and the odds increased significantly with the reduction of household wealth index.
Journal ArticleDOI
Does treatment of intestinal helminth infections influence malaria? Background and methodology of a longitudinal study of clinical, parasitological and immunological parameters in Nangapanda, Flores, Indonesia (ImmunoSPIN Study)
Aprilianto E. Wiria,Aprilianto E. Wiria,Margaretta A. Prasetyani,Firdaus Hamid,Firdaus Hamid,Linda J. Wammes,Bertrand Lell,Iwan Ariawan,Hae-Won Uh,Heri Wibowo,Yenny Djuardi,Sitti Wahyuni,Inge Sutanto,Linda May,Adrian J. F. Luty,Jaco J. Verweij,Erliyani Sartono,Maria Yazdanbakhsh,Taniawati Supali +18 more
TL;DR: The area of Nangapanda on Flores Island, Indonesia, where malaria and helminth parasites are co-endemic was selected for a longitudinal study, and a Double-blind randomized trial will be performed, incorporating repeated treatment with albendazole (400 mg) or placebo at three monthly intervals.
Journal ArticleDOI
Use of active management of the third stage of labour in seven developing countries
Cynthia Stanton,Deborah Armbruster,Rod Knight,Iwan Ariawan,Sourou Gbangbade,Ashebir Getachew,Jose Angel Portillo,Douglas Jarquin,Flor Marin,Sayoka Mfinanga,Jesus Vallecillo,Hope L. Johnson,David Sintasath +12 more
TL;DR: In this article, the use of active management of the third stage of labour for preventing postpartum haemorrhage and exploring factors associated with such use in seven developing countries was explored.
Journal ArticleDOI
The Effect of Three-Monthly Albendazole Treatment on Malarial Parasitemia and Allergy: A Household-Based Cluster-Randomized, Double-Blind, Placebo-Controlled Trial
Aprilianto E. Wiria,Aprilianto E. Wiria,Firdaus Hamid,Firdaus Hamid,Linda J. Wammes,Maria M. M. Kaisar,Maria M. M. Kaisar,Linda May,Margaretta A. Prasetyani,Margaretta A. Prasetyani,Sitti Wahyuni,Yenny Djuardi,Yenny Djuardi,Iwan Ariawan,Heri Wibowo,Bertrand Lell,Bertrand Lell,Robert W. Sauerwein,Gary T. Brice,Inge Sutanto,Lisette van Lieshout,Anton J. M. de Craen,Ronald van Ree,Jaco J. Verweij,Roula Tsonaka,Jeanine J. Houwing-Duistermaat,Adrian J. F. Luty,Erliyani Sartono,Taniawati Supali,Maria Yazdanbakhsh +29 more
TL;DR: The study indicates that intensive community treatment of 3 monthly albendazole administration for 21 months over two years leads to a reduction in STH, and this degree of reduction appears safe without any increased risk of malaria or allergies.